Melatonin and taurine reduce early glomerulopathy in diabetic rats

Free Radical Biology and Medicine

Volumn 26, Issue 7-8, 1999, Pages 944-950

  Ha, Hunjoo ^a   Yu, Mi Ra ^a   Kim, Kyung Hwan ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Diabetic glomerulopathy; Fibronectin; Free radical; Melatonin; Oxidative stress; Streptozotocin; Taurine; TGF 1

Indexed keywords

DNA; DRINKING WATER; FIBRONECTIN; GLUCOSE; LIPID PEROXIDE; MELATONIN; MESSENGER RNA; PROTEIN; STREPTOZOCIN; TAURINE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULOPATHY; HYPERGLYCEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; NORTHERN BLOTTING; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DIURESIS; FIBRONECTINS; GENE EXPRESSION REGULATION; KIDNEY GLOMERULUS; LIPID PEROXIDATION; MALE; MELATONIN; OXIDATIVE STRESS; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TAURINE; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 0032923362     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00276-7     Document Type: Article

References (47)

1. Reichard P., Neilsson B-Y, Roseuqvist U. The effect of long term-intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N. Eng. J. Med. 329:1993;304-309.
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329:1993;977-986.
3. Larkins R.G., Dunlop M.E. The link between hyperglycemia and diabetic nephropathy. Diabetologia. 35:1992;499-504.
4. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1991;405-412.
5. Wolff S.P., Jiang Z.Y., Hunt J.V. Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radical Biol. Med. 10:1991;339-352.
6. Ha H., Tojo A., Endou H. Proximal tubular dysfunction as a cause of diabetic microalbuminuria. The Physiologist. 34:1991;249. (abstr.).
7. Ha H., Kim C., Son Y., Chung M.H., Kim K.H. DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free Radical Biol. Med. 16:1994;271-274.
8. Ha H., Yoon S.J., Kim K.H. High glucose can induce lipid peroxidation in the isolated rat glomeruli. Kidney Int. 46:1994;1620-1626.
9. Ha, H.; Lee, S. H.; Kim, K. H. Effects of rebamipide in a model of experimental diabetes and on the synthesis of transforming growth factor-β and fibronectin, lipid peroxidation induced by high glucose in cultured mesangial cells. J. Pharmacol. Exp. Ther. 28:1497-1462; 1997.
10. Trachtman H., Futterweit S., Bienkowski R.S. Taurine prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Biochem. Biophys. Res. Commun. 191:1993;759-765.
11. Trachtman H. Vitamin E prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Microvasc. Res. 47:1994;232-239.
12. Trachtman H., Futterweit S., Maesaka J., Ma C., Valderrama E., Fuchs A., Tarectecan A.A., Rao P., Sturman J.A., Boles T.H., Fu M., Baynes J. Taurine ameliorates chronic streptozotocin-induced diabetic nephropathy in rats. Am. J. Physiol. 269:1995;F429-F438.
13. Craven P.A., Derubertis F.R., Kagan V.E., Melhem M., Studer R.K. Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-β, and glomerular size in diabetes. J. Am. Soc. Nephrol. 8:1997;1405-1414.
14. Koya D., Lee I-K, Ishii H., Kanoh H., King G.L. Prevention of glomerular dysfunction in diabetic rats by treatment with d-α-tocopherol. J. Am. Soc. Nephrol. 8:1997;426-435.
15. Ruiz-Munoz L.M., Vidal-Vanacloch F., Lampreabe I. Enalaprilat inhibits hydrogen peroxide production by murine mesangial cells exposed to high glucose concentrations. Nephrol. Dial. Transplant. 12:1997;456-464.
16. Kahler W., Kuklinski B., Ruhlmann C., Plotz C. Diabetes mellitus A free-radical associated disease. Results of an adjuvant antioxidant supplementation . Innere. Medizin. 48:1993;223-232.
17. Ha H., Kim K.H. Role of oxidative stress in the development of diabetic nephropathy. Kidney Int. 48:(Suppl 51):1995;S18-S21.
18. Ayo S.H., Radnik R.A., Garoni J., Glass W.F. II, Kreisberg J.I. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am. J. Pathol. 136:1990;1339-1348.
19. Ayo S.H., Radnik R.A., Glass W.F. II, Garoni J., Rampt E.R., Appling D.R., Kreisberg J.I. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high glucose medium. Am. J. Physiol. 260:1991;F185-F191.
20. Nagamatsu M., Nickander K.K., Schmelzer J.D., Raya A., Wittrock D.A., Tritschler H., Low P.A. Lipoic acid improves nerve blood flow, reduces oxidative stress and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care. 18:1995;1160-1167.
21. Giugliano D., Marfella R., Verrazzo G., Acampora R., Donzella C., Quatraro A., Coppola L., D'Onofrio F. Abnormal rheologic effects of glyceryl trinitrate in patients with noninsulin dependent diabetes mellitus and reversal by antioxidants. Am. Intern. Med. 123:1995;338-343.
22. Ting H.H., Timimi F.K., Boles K.S., Creager S.J., Ganz P., Creager M.A. Vitamin C improves endothelium dependent vasodilatation in patient with noninsulin dependent diabetes mellitus. J. Clin. Invest. 97:1996;22-28.
23. Reiter R.J., Tang L., Garcia J.J., Munoz-Hoyos A. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci. 60:1997;2255-2271.
24. Wright C.E., Tallan H.H., Lin Y.Y. Taurine Biological update . Ann. Rev. Biochem. 55:1986;427-453.
25. Huxtable R.J. Physiological actions of taurine. Physiol. Rev. 72:1992;101-163.
26. Trachtman H., Cel Pizzo R., Futterweit S., Levine D., Rao P.S., Valderrama E., Sturman J.A. Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy. Am. J. Physiol. 262:1992;F117-F123.
27. Mauer S.M., Steffes M.W., Ellis E.N., Sutherland D.E.R., Brown D.M., Goetz F.C. Structural functional relationships in diabetic nephropathy. J. Clin. Invest. 74:1984;1143-1155.
28. Fukui M., Nakamura T., Ebihara I., Shirato I., Tomino Y., Koide H. ECM gene expression and its modulation by insulin in diabetic rats. Diabetes. 41:1992;1520-1527.
29. Park I.S., Kiyomoto H., Abboud S.L., Abboud H.E. Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes. Diabetes. 46:1997;473-480.
30. Pugliese G., Pricci F., Pesce C., Romeo G., Lenti E., Caltabiano V., Verti M., Purrello F., Di Mario U. Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats. Diabetes. 46:1997;1198-1206.
31. Ziyadeh F.N., Han D.C. Involvement of transforming growth factor-b and its receptors in the pathogenesis of diabetic nephropathy. Kidney Int. 52:(Suppl 60):1997;S7-S11.
32. Border W.A., Yamamoto Y., Noble N.A. Transforming growth factor-β in diabetic nephropathy. Diabetes/Metabol. Rev. 12:1996;309-339.
33. Nakamura T., Fukui M., Ebihara I., Osada S., Nagaoka I., Tomino Y., Koide H. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes. 42:1993;450-456.
34. Yamamoto T., Nakamura T., Noble N.A., Rouslahti E., Border W.A. Expression of transforming growth factor-β is elevated in human and experimental diabetic nephropathy. Proc. Natl. Acad. Sci. 90:1993;1814-1818.
35. Shankland S.J., Scholey J.W. Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int. 46:1994;430-442.
36. Han D.C., Kim J.H., Cha M.K., Song K.I., Hwang S.D., Lee H.B. Effects of HMG CoA reductase inhibition on TGF-β1 mRNA expression in diabetic rat glomeruli. Kidney Int. 48:(Suppl 51):1995;S61-S65.
37. Young B.A., Johnson R.J., Alpers C.E., Eudora E., Gordon K., Gloege J., Couseer W.G. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int. 47:1995;935-944.
38. Han D.C., Kim Y.J., Cha M.K., Song K.I., Kim J.H., Lee E.Y., Ha H., Lee H.B. Glucose control suppressed the glomerular expression of TGF-β1 and the progression of experimental diabetic nephropathy. J. Am. Soc. Nephrol. 7:1996;1870. (abstr.).
39. Piechaczyk M., Blanchard J.M., Marty L., Dani Ch., Panabieres F., El Sabouty S., Fort Ph., Jeanteur Ph. Post-transcriptional regulation of glyceraldehyde-3- phosphate-dehydrogenase gene expression in rat tissues. Nucleic Acid Res. 12:1984;6951-6963.
40. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:1979;351-358.
41. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
42. Nath K.A., Grande J., Croatt A., Haugen J., Kim Y., Rosenberg M.E. Redox regulation of renal DNA synthesis, transforming growth factor-β1 and collagen gene expression. Kidney Int. 53:1998;367-381.
43. Ha H., Kim K.H. Role of protein kinase C-mediated oxidative stress in increased TGF-β1 and fibronectin mRNAs in mesangial cells Implications for diabetic nephropathy . Nephrology. 3:(Suppl 1):1997;A736. (abstr.).
44. Studer R.K., Craven P.A., DeRubertis F.R. Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells. Met. Clin. Exp. 46:1997;918-925.
45. King G.L., Ishii H., Koya D. Diabetic vascular dysfunctions A model of excessive activation of protein kinase C . Kidney Int. 52:(Suppl 60):1997;S77-S85.
46. Gopalkrishna R., Anderson W.B. Reversible oxidative activation and inactivation of protein kinase C by the mitogen/tumor promotor periodate. Arch. Biochem. Biophys. 285:1991;382-387.
47. Gschwendt M., Kittstein W., Marks F. Protein kinase C activation by phorbol esters Do cysteine rich regions and pseudosubstrate motifs play a role? Trends Biochem. Sci. 16:1991;167-169.